|
MED7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79929959820413E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3844000001928E-07 |
| Normal-vs-Stage2 |
4.097600E-03 |
| Normal-vs-Stage3 |
4.96158669704982E-13 |
| Normal-vs-Stage4 |
1.59459999649059E-08 |
| Stage1-vs-Stage2 |
6.698800E-01 |
| Stage1-vs-Stage3 |
1.964330E-04 |
| Stage1-vs-Stage4 |
4.222100E-02 |
| Stage2-vs-Stage3 |
1.760460E-02 |
| Stage2-vs-Stage4 |
1.134240E-01 |
| Stage3-vs-Stage4 |
2.784600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8866996853717E-10 |
| Normal-vs-AfricanAmerican |
3.845700E-04 |
| Normal-vs-Asian |
3.936600E-03 |
| Caucasian-vs-AfricanAmerican |
1.798210E-01 |
| Caucasian-vs-Asian |
4.315000E-01 |
| AfricanAmerican-vs-Asian |
1.545970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78469477979593E-11 |
| Normal-vs-Female |
8.30489999992245E-07 |
| Male-vs-Female |
3.526400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.184400E-04 |
| Normal-vs-Age(41-60Yrs) |
7.22990000090462E-08 |
| Normal-vs-Age(61-80Yrs) |
1.36519684446057E-11 |
| Normal-vs-Age(81-100Yrs) |
1.784380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.469800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.313600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.369900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.096200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.357600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.534400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.006100E-02 |
| Normal-vs-Grade 2 |
2.74439999947695E-07 |
| Normal-vs-Grade 3 |
4.31059999916883E-08 |
| Normal-vs-Grade 4 |
1.80933046323162E-12 |
| Grade 1-vs-Grade 2 |
7.089800E-01 |
| Grade 1-vs-Grade 3 |
5.458000E-01 |
| Grade 1-vs-Grade 4 |
1.028290E-02 |
| Grade 2-vs-Grade 3 |
4.982600E-01 |
| Grade 2-vs-Grade 4 |
3.01930000001782E-06 |
| Grade 3-vs-Grade 4 |
1.000800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.975500E-04 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
5.31159560779315E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49859999859703E-08 |
| Normal-vs-N1 |
1.01429999954661E-07 |
| N0-vs-N1 |
6.442400E-03 |
|
|
